CN110551069A - synthesis method of 5-phenylpentanol compound and intermediate thereof - Google Patents

synthesis method of 5-phenylpentanol compound and intermediate thereof Download PDF

Info

Publication number
CN110551069A
CN110551069A CN201810551701.2A CN201810551701A CN110551069A CN 110551069 A CN110551069 A CN 110551069A CN 201810551701 A CN201810551701 A CN 201810551701A CN 110551069 A CN110551069 A CN 110551069A
Authority
CN
China
Prior art keywords
compound
solvent
reaction
mol
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810551701.2A
Other languages
Chinese (zh)
Other versions
CN110551069B (en
Inventor
殷亮
钟锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN201810551701.2A priority Critical patent/CN110551069B/en
Publication of CN110551069A publication Critical patent/CN110551069A/en
Application granted granted Critical
Publication of CN110551069B publication Critical patent/CN110551069B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

The invention discloses a synthesis method of a 5-phenylpentanol compound and an intermediate thereof, which comprises the following steps of carrying out the following reaction on a compound 1 and a compound 2 in a solvent under the action of organic base and Cu (CH 3 CN) 4 PF 6 and (S) -DTBM-SEGPHOS to obtain a compound 3

Description

synthesis method of 5-phenylpentanol compound and intermediate thereof
Technical Field
the invention relates to a method for synthesizing a 5-phenylpentanol compound and an intermediate thereof.
Background
Neurokinin substance P is involved in biological responses such as neuroinflammation, pain transmission, and regulation of immune responses in vivo (Harrison, T.; Williams, B.J.; Swain, C.J.; Ball, R.G. Bioorg.Med.Chem.Lett.1994,4, 2545-. (+) -CP-99,994 and (+) -L-733,060 are potent and selective neurokinin substance P receptor antagonists (Liu, R. -H.; Fang, K.; Wang, B.; Xu, M. -H.; Lin, G. -Q.J.Org.Chem.2008,73, 3307-. (+) -CP-99,994 and (+) -L-733,060 have attracted interest to organic synthesizers. In the synthesis work, a chiral substrate is mainly used, the chirality of the product is controlled through the substrate, the obtained chiral substrate is generally obtained through chiral resolution, the process is complicated, and the 5-phenylpentanol compound 6 of (+) -CP-99,994 and (+) -L-733,060 (Mandar, S.B.; Upadhyy, P.K.; Kumar, P.tetrahedron Lett.2004,45, 987-:
In organic synthesis, vinylogous Mannich type reactions can be induced by chirality to generate stereoselective products. The traditional vinylogous reaction needs to prepare a substrate into dienol silyl ether in advance, equivalent silicon waste is generated after the reaction, and the atom economy is poor.
Therefore, the development of asymmetric direct vinylogous Mannich type reaction, and the realization of high reactivity, high regioselectivity, high diastereoselectivity and high enantioselectivity are the problems to be solved in the field.
disclosure of Invention
The invention provides a synthetic method of a 5-phenylpentanol compound and an intermediate thereof, aiming at overcoming the defects of more waste materials, poor atom economy and the like in a vinylon Mannich reaction in the prior art. The method has the following advantages: obtaining a chiral intermediate through asymmetric catalytic prochiral substrate reaction, and obtaining a 5-phenylpentanol compound 6 through simple conversion; the used catalyst is cheap and easy to obtain, the catalyst dosage is low, the reaction condition is mild, the related route is simple, and the product yield and purity are high; pyrazole amide of bromocrotonic acid is used as a substrate, and directly reacts with aldimine to carry out vinylon Mannich type reaction, so that high reactivity, high regioselectivity, high diastereoselectivity and high enantioselectivity are realized, the post-treatment is simple, and the method is suitable for industrial production.
The invention provides a method for synthesizing a compound 3, which comprises the following steps of carrying out the following reaction on a compound 1 and a compound 2 in a solvent under the action of organic base and Cu (CH 3 CN) 4 PF 6 and (S) -DTBM-SEGPHOS to obtain the compound 3;
In the synthesis method of compound 3, the solvent may be a conventional solvent in the art for performing such a reaction, preferably an ether solvent, and more preferably tetrahydrofuran. The amount of the solvent can be the conventional amount for carrying out the reaction in the field as long as the reaction is not influenced; the volume mol ratio of the compound to the compound 1 is preferably 15-25L/mol, such as: 19.5L/mol.
in the synthesis method of the compound 3, the organic base can be a conventional solvent for performing such reactions in the field, preferably one or more of TEA, Cy 2 NMe, DIPEA, TMG and Barton's base, more preferably TEA, and the organic base can be used in an amount conventional for performing such reactions in the field, preferably, the molar ratio of the organic base to the compound 1 is 0.02-0.1, for example, 0.05.
in the synthesis method of the compound 3, the amount of the Cu (CH 3 CN) 4 PF 6 can be the amount conventionally used in the art for carrying out such reactions, and is preferably 0.02 to 0.1, for example, 0.05 in terms of molar ratio to the compound 1.
In the synthesis method of the compound 3, the (S) -DTBM-SEGPHOS can be used in the conventional amount for carrying out the reaction in the field, and the molar ratio of the (S) -DTBM-SEGPHOS to the compound 1 is preferably 0.02-0.1, for example, 0.05.
in the synthesis method of the compound 3, the compound 2 can be used in an amount which is conventional in the art for carrying out such reactions, and preferably the molar ratio of the compound 2 to the compound 1 is 1.0-3.0, for example, 2.0.
in the synthesis method of the compound 3, the reaction is preferably carried out under anhydrous conditions.
in the method for synthesizing compound 3, the reaction temperature may be a temperature conventionally used in the art for carrying out such a reaction, and is preferably 0 ℃ to-60 ℃, for example, -40 ℃.
Among the synthetic methods of the compound 3, the preferred synthetic method of the compound 3 includes the steps of mixing Cu (CH 3 CN) 4 PF 6, (S) -DTBM-SEGPHOS with a solvent, then mixing with the compound 1 and the compound 2, and then mixing with the organic base to perform the reaction to obtain the compound 3, the preferred method is to mix Cu (CH 3 CN) 4 PF 6, (S) -DTBM-SEGPHOS with a solvent, add the compound 1 and the compound 2, and then add the organic base to perform the reaction under anhydrous conditions, and the addition temperature of the organic base is preferably 0 ℃ to-60 ℃, for example, -40 ℃.
In the synthesis method of the compound 3, the progress of the reaction can be detected by a conventional monitoring method in the art (such as TLC, HPLC or NMR), and generally the end point of the reaction is the disappearance of the compound 1, and the reaction time is preferably 24 to 60 hours, for example, 48 hours.
In the synthesis method of the compound 3, the reaction can further comprise post-treatment after the reaction is finished; the work-up procedure is a conventional work-up procedure for such reactions, preferably comprising the following steps: after the reaction is finished, concentrating and carrying out column chromatography to obtain a compound 3. The method and conditions for column chromatography may be those conventional in the art for such procedures.
the invention also provides a synthesis method of the compound 4, which comprises the following steps: in a solvent, the compound 3 prepared by the method and silver salt react to obtain a compound 4 as shown in the specification;
in the synthesis method of compound 4, the solvent may be a conventional solvent in the art for performing such a reaction, preferably a nitrile solvent, more preferably acetonitrile. The amount of the solvent can be the conventional amount for carrying out the reaction in the field as long as the reaction is not influenced; the volume mol ratio of the compound to the compound 3 is preferably 8.0-20L/mol, such as: 11.49L/mol.
in the synthesis method of the compound 4, the silver salt can be a conventional silver salt for carrying out the reaction in the field, preferably one or more of AgTFA, AgOTf, AgBF 4 or AgSCF 3, the dosage of the silver salt can be a conventional dosage for carrying out the reaction in the field, and the molar ratio of the silver salt to the compound 3 is preferably 1.0-2.0, for example, 1.49.
in the synthesis method of the compound 4, the reaction is preferably carried out under anhydrous conditions.
In the synthesis of compound 4, the reaction temperature may be a temperature conventional in the art for carrying out such a reaction, preferably 40 ℃ to 60 ℃, for example, 50 ℃.
Among the synthetic methods of compound 4, the preferred synthetic method of compound 4 comprises the following steps: the compound 3, silver salt and solvent are mixed and the reaction is carried out to obtain the compound 4. Preferably, the reaction is carried out by mixing compound 3 and a silver salt under anhydrous conditions and adding a solvent.
In the synthesis method of the compound 4, the progress of the reaction can be detected by a conventional monitoring method in the art (such as TLC, HPLC or NMR), and generally the end point of the reaction is determined when the compound 3 disappears, and the reaction time is preferably 6-10 hours, for example, 8 hours.
In the synthesis method of the compound 4, the reaction can further comprise post-treatment after the reaction is finished; the work-up procedure is a conventional work-up procedure for such reactions, preferably comprising the following steps: after the reaction is finished, cooling, filtering, concentrating the filtrate, and carrying out column chromatography to obtain the compound 4. The method and conditions for column chromatography may be those conventional in the art for such procedures.
The invention also provides a synthesis method of the compound 5, which comprises the following steps: in a solvent, carrying out the reaction of the compound 4 prepared by the method under the action of a reducing agent to obtain a compound 5;
In the synthesis method of compound 5, the solvent may be a conventional solvent for performing such a reaction in the art, and preferably a mixed solvent of an organic solvent and water. The organic solvent is preferably an alcohol solvent and/or an ether solvent. The alcohol solvent is preferably one or more of methanol, ethanol and isopropanol. The ether solvent is preferably tetrahydrofuran. The volume ratio of the organic solvent to the water in the mixed solvent is preferably 2: 1-6: 1, e.g., 4: 1. the amount of the solvent can be the conventional amount for carrying out the reaction in the field as long as the reaction is not influenced; the volume mol ratio of the compound to the compound 4 is preferably 12-20L/mol, such as: 16.0L/mol.
in the synthesis of compound 5, the reducing agent may be a conventional reducing agent used in the art for performing such reactions, preferably a borohydride of an alkali metal, more preferably sodium borohydride. The reducing agent can be used in an amount conventionally used in the art for carrying out such a reaction, and preferably, the molar ratio of the reducing agent to the compound 4 is 6.0 to 10.0, for example, 8.0.
In the synthesis method of compound 5, the reaction temperature may be a conventional temperature for performing such a reaction in the art, preferably room temperature.
the preferred synthesis method of compound 5 comprises the following steps: adding a reducing agent into a solution of the compound 4 and a solvent, and carrying out the reaction at the temperature to obtain a compound 5. The reducing agent may be added at a temperature conventional in the art for carrying out such reactions, preferably from-5 ℃ to 5 ℃, e.g., 0 ℃.
In the synthesis method of the compound 5, the progress of the reaction can be detected by a conventional monitoring method in the art (such as TLC, HPLC or NMR), and generally the end point of the reaction is determined when the compound 4 disappears, and the reaction time is preferably 1 to 5 hours, for example, 3 hours.
in the synthesis method of the compound 5, the reaction can further comprise post-treatment after the reaction is finished; the work-up procedure is a conventional work-up procedure for such reactions, preferably comprising the following steps: after the reaction is finished, adding water to quench the reaction, extracting by using an organic solvent, drying, concentrating and carrying out column chromatography to obtain a compound 5. The method and conditions for column chromatography may be those conventional in the art for such procedures.
The invention also provides a synthesis method of the compound A, which comprises the following steps: under the action of inorganic base, compound 5 prepared by the method is subjected to hydrolysis reaction as shown in the specification to obtain compound A;
In the synthesis method of compound a, the solvent may be a conventional solvent for performing such a reaction in the art, and preferably an alcohol solvent and/or an ether solvent. The alcoholic solvent may be a conventional alcoholic solvent used in the art for such reactions, preferably one or more of methanol, ethanol and isopropanol. The ether solvent is preferably tetrahydrofuran. The amount of the solvent can be the conventional amount for carrying out the reaction in the field as long as the reaction is not influenced; the volume mol ratio of the compound to the compound 5 is preferably 10.5-26.3L/mol, such as: 21.05L/mol.
in the synthesis method of compound a, the inorganic base may be a conventional inorganic base used in the art for performing such a reaction, and is preferably an alkali metal hydroxide, more preferably sodium hydroxide and/or potassium hydroxide. The amount of the inorganic base can be the conventional amount for carrying out the reaction in the field as long as the reaction is not influenced; preferably, the molar ratio of the compound 5 to the compound is 8.0 to 15.0, for example, 12.6. The inorganic base is preferably present in the reaction in the form of an aqueous solution of the inorganic base. The aqueous solution of the inorganic base may have a molar concentration conventional in such reactions in the art, preferably from 1mol/L to 10mol/L, more preferably from 1mol/L to 5mol/L, for example: 2 mol/L.
in the synthesis of compound a, the temperature of the hydrolysis reaction may be a temperature conventional in the art for carrying out such a reaction, preferably 60 ℃ to 100 ℃, for example, 80 ℃.
in the method for synthesizing the compound a, the progress of the hydrolysis reaction can be detected by a conventional monitoring method in the art (such as TLC, HPLC or NMR), and generally the time when the compound 5 disappears is used as a reaction end point, and the reaction time is preferably 12 to 20 hours.
In the synthesis method of the compound A, the hydrolysis reaction can further comprise post-treatment after the reaction is finished; the work-up procedure is a conventional work-up procedure for such reactions, preferably comprising the following steps: and after the reaction is finished, cooling, adding an organic solvent for dilution, drying and concentrating to obtain the compound A.
the invention also provides a synthesis method of the 5-phenylpentanol compound 6, which comprises the following steps of carrying out the following reaction on the compound A prepared by the previous method and (Boc) 2 O in a solvent to obtain the 5-phenylpentanol compound 6;
In the method for synthesizing the 5-phenylpentanol compound 6, the organic solvent can be a conventional organic solvent for carrying out such a reaction in the field, and is preferably a halogenated hydrocarbon solvent and/or an ether solvent. The halogenated hydrocarbon solvent is preferably chloroform. The ether solvent is preferably tetrahydrofuran. The organic solvent can be used in an amount which is conventional in the art for carrying out such a reaction, and preferably has a volume mol ratio of 15-25L/mol to the compound A, for example: 21.05L/mol.
In the synthesis method of the 5-phenylpentanol compound 6, the (Boc) 2 O can be used in an amount which is conventional in the field for carrying out the reaction, preferably the molar ratio of the (Boc) 2 O to the compound A is 1.0-2.0, for example, 1.2. the dropping temperature of the (Boc) 2 O can be conventional in the field for carrying out the reaction, preferably-5 ℃, for example, 0 ℃.
In the method for synthesizing the 5-phenylpentanol compound 6, the reaction temperature can be a conventional temperature for performing such a reaction in the art, preferably room temperature.
In the method for synthesizing the 5-phenylpentanol compound 6, the progress of the reaction can be detected by a conventional monitoring method in the field (such as TLC, HPLC or NMR), the end point of the reaction is generally used when the compound A disappears, and the reaction time is preferably 10-20 hours.
In the synthesis method of the 5-phenylpentanol compound 6, the reaction can further comprise post-treatment after the reaction is finished; the work-up procedure is a conventional work-up procedure for such reactions, preferably comprising the following steps: after the reaction is finished, adding water to quench the reaction, extracting by an organic solvent, washing by water, drying, concentrating, and carrying out column chromatography to obtain the 5-phenylpentanol compound 6. The method and conditions for column chromatography may be those conventional in the art for such procedures.
The invention also provides an intermediate for synthesizing the 5-phenylpentanol compound 6, which has the following structure:
the above preferred conditions can be arbitrarily combined to obtain preferred embodiments of the present invention without departing from the common general knowledge in the art.
The preparation of the starting compound 2 used in the present invention is referred to in Kanazawa, a.m.; denis, j.; greene, A.E.J.org.chem.1984,59,1238-1240, other reagents and starting materials are commercially available.
in the present invention, the operation is carried out at room temperature unless otherwise specified. The room temperature is 0-35 ℃, preferably 20-30 ℃.
In the present invention, the Barton's Base is 2-tert-butyl-1, 1,3, 3-tetramethylguanidine (CAS: 29166-72-1); the TMG is tetramethylguanidine (CAS: 80-70-6).
the positive progress effects of the invention are as follows:
(1) Obtaining a chiral intermediate through asymmetric catalytic prochiral substrate reaction, and obtaining the 5-phenylpentanol compound 6 through simple conversion.
(2) the catalyst used in the key reaction is cheap and easy to obtain, the dosage is low, the reaction condition is mild, the related route is simple, and the yield and the purity of the product are high.
(3) Pyrazole amide of bromo-crotonic acid is used as a substrate to directly generate an vinylon-inserting Mannich type reaction with aldimine, so that high reactivity, high regioselectivity, high diastereoselectivity and high enantioselectivity are successfully realized, the post-treatment is simple, and the method is suitable for industrial production.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.
In the following examples, the specific operation temperature is not limited, and it is meant to be carried out at room temperature (0 to 35 ℃ C.).
in the following examples calcd means the calculated value and found means the actual value.
example 1
compound 1: adding a compound (E) -1- (3,5-diphenyl-1H-pyrazol-1-yl) but-2-en-1-one (Sibi, M.P.; Itoh, K.J.Am.Chem.Soc.2007,129,8064-8065.) (30mmol,8.65g) into a dry 250mL eggplant-shaped bottle, adding 100mL of carbon tetrachloride to dissolve, sequentially adding NBS (36mmol,6.41g) and AIBN (0.9mmol,148mg), freezing and extracting the solution for three times to remove oxygen, recovering the room temperature, heating to 90 ℃ under the protection of nitrogen, refluxing for 12H, naturally cooling to the room temperature, filtering, washing filter residues by a small amount of carbon tetrachloride column chromatography, concentrating the filtrate, and obtaining a product 1 (white solid, 6.7g, 61%).
1H NMR(400MHz,CDCl3)δ7.95-7.85(m,2H),7.67(d,J=15.3Hz,1H),7.53-7.34(m,8H),7.23-7.15(dd,J=7.6Hz,15.3Hz,1H),4.13(d,J=7.5Hz,2H)ppm.13C NMR(100MHz,CDCl3)δ163.33,153.76,147.71,143.75,131.53,130.94,129.37,128.97,128.91,128.86,127.96,126.33,124.22,110.39,29.47ppm.MS(ESI,M+H+):367.05.HRMS(ESI,M+H+):m/z calcd.367.0441,found367.0439.
Compound 3 is weighed into an oven dried 100mL Schlenk bottle as Cu (CH 3 CN) 4 PF 6 (55.9mg, 0.15mmol) and (S) -DTBM-SEGPHOS (177mg, 0.15mmol), removed from the glove box, THF (58.5mL) is added, stirred at room temperature for 15min, 1(1.10g,3.0mmol) and aldimine 2 (572.23 g,6.0mmol) are added, cooled in a-40 ℃ cold bath, finally a solution (0.1M in THF,1.5mL) is added, column chromatography is performed at 40 ℃ for 48 hours to obtain product 3 (PE: EA: 10:1), which is obtained as a white solid, 1.53g, 89%, 11/1dr, > 99% ee, 1 H NMR (400MHz, CDCl 3) delta 7.94-7.89(M,2H ESI), 7.67(d, 15J, 15.25 dr, > 99% ee), 7.7.7H 29 MHz, 7H 19H 29 MHz, 7.8H 29H 19, 26M, 7.8H 29 Hz, 7.8H 29H 8, 7H 29H 5 Hz, 7H 8, 7H 29H 8, 7H 26H 5 Hz, 7H 5H 7H 5H 8H 7H 8H 7H 8H 7H 5 Hz, 8H 5 Hz, 8H 5H.
Compound 4, AgTFA (289mg,1.3mmol) and compound 3(500mg,0.87mmol) are weighed in a glove box and removed from the glove box, CH 3 CN (10mL) is added, the sealed tube is placed in a 50 ℃ oil bath to be heated for 8 hours and then naturally cooled, the reaction solution is filtered by diatomite, the filtrate is concentrated and then subjected to flash column chromatography (PE/EA 2/1) to obtain compound 4 (white solid, 35mg, 92% >, 1 dr, 1 H NMR (400MHz, CDCl 3), δ 7.94-7.87(M,2H),7.72-7.63(dd, J15.6 Hz,1H),7.51-7.15(M,13H),6.72(s,1H),6.55-6.46(dd, J ESI 15.6Hz,1H), 6.14-6.07H, 5H (1H), 5H, 24 mg, 24.18 mg, 24H, 24 mg, 24H, 24, 5H, 24, 5mg, 5H, 24, 5H, 24 mg, 24.
Compound 5. Compound 4(218mg,0.50mmol) was added to a 25mL eggplant-shaped flask, THF/H 2 O (6.4mL/1.6mL) was added, NaBH 4 (151mg,4.0mmol) was slowly added at 0 deg.C, the reaction system naturally returned to room temperature, after continuing the reaction at room temperature for 3 hours, hydrochloric acid (1M,20mL) was added to quench, DCM was extracted three times, the organic phases were combined and dried over anhydrous sodium sulfate, flash column chromatography (PE/EA ═ 1:2) was performed after concentration to give compound 5 (white solid, 91.5mg, 83%, >20/1dr 865) 1 H NMR (400MHz, CDCl 3) delta 7.46-7.16(M,5H),5.40(s,1H),4.96-4.83(M,2H),3.62-3.44(M,2H),1.75-1.46 (ESIm, 2H), 1.34-1H (M, 17.17M, 5H), 4.83(M,2H),3.62-3.44(M, 27.75 ppm, 27.27, 24.27 ppm, 24.27, 24.27.27 ppm, 24.27.27, 25.27 ppm, 24 ppm, 24.27, 24 ppm, 24.11, 24.
Compound 6, Compound 5(85mg,0.38mmol) was put into a 25mL eggplant-shaped bottle, CH 3 OH (8mL) was added, KOH solution (2.4mL,2M) was added, oil bath was carried out at 80 ℃ for 16 hours, then the mixture was naturally cooled to room temperature, DCM (20mL) was added to the reaction mixture to dilute the mixture, anhydrous magnesium sulfate was dried and suction-filtered, the filtrate was concentrated and dissolved in CHCl 3, then (Boc) 2 O (100mg,0.46mmol) was added dropwise at 0 ℃, the reaction was continued for 12 hours after the room temperature was naturally returned, the reaction mixture was quenched with water and DCM was extracted three times, the organic phase was washed with saturated NaHCO 3 solution and saturated sodium chloride, anhydrous sodium sulfate was dried and the organic phase was concentrated, flash column chromatography (PE/EA: 1/1) was carried out to obtain Compound 6 (white solid, 82mg, 73%, >20/1dr), 1 H NMR (400MHz, CDCl 3) delta 7.38-7.30(M,5H),5.66-5.51 b (1H), 296, 1H 3.72-24.7.38-7H, 3.26M, 11M, 3.26H, 96M, 96-7.26M, 96H, 11M, 96.7.26M, 3.7-7.7, 3.7H, 3.7-7H, 3.7H, 3, 3.7M, 3, 3.7H, 11M, 3, 3.8.7-7.7, 3.26, 3.7H, 3, 3.26, 3.8.7, 3, 3.8.8, 3.7.

Claims (12)

1. A method for synthesizing a compound 3 is characterized by comprising the steps of reacting a compound 1 with a compound 2 in a solvent under the action of an organic base and under the action of Cu (CH 3 CN) 4 PF 6 and (S) -DTBM-SEGPHOS to obtain the compound 3;
2. The method of synthesis according to claim 1,
the solvent is an ether solvent;
and/or the volume mol ratio of the solvent to the compound 1 is 15-25L/mol;
And/or the organic base is one or more of TEA, Cy 2 NMe, DIPEA, TMG and Barton's base;
And/or the molar ratio of the organic base to the compound 1 is 0.02-0.1;
And/or the molar ratio of the Cu (CH 3 CN) 4 PF 6 to the compound 1 is 0.02-0.1;
And/or the molar ratio of the (S) -DTBM-SEGPHOS to the compound 1 is 0.02-0.1;
And/or the molar ratio of the compound 2 to the compound 1 is 1.0-3.0;
And/or, the reaction is carried out under anhydrous conditions;
And/or the temperature of the reaction is 0 ℃ to-60 ℃.
3. The method of synthesis according to claim 2,
The solvent is tetrahydrofuran;
and/or the organic base is TEA;
and/or, the synthetic method of the compound 3 comprises the following steps of mixing Cu (CH 3 CN) 4 PF 6 and (S) -DTBM-SEGPHOS with a solvent, then mixing with the compound 1 and the compound 2, and then mixing with the organic base to carry out the reaction to obtain the compound 3, preferably mixing Cu (CH 3 CN) 4 PF 6 and (S) -DTBM-SEGPHOS with the solvent under the anhydrous condition, adding the compound 1 and the compound 2, and then adding the organic base to carry out the reaction, wherein the adding temperature of the organic base is preferably 0-60 ℃.
4. a method for synthesizing a compound 4, which is characterized by comprising the following steps: in a solvent, the compound 3 and a silver salt react as shown below to obtain a compound 4; the synthesis method of the compound 3 is as described in any one of claims 1 to 3;
5. The method of synthesis according to claim 4,
The solvent is a nitrile solvent, preferably acetonitrile;
And/or the volume mol ratio of the solvent to the compound 3 is 8.0-20L/mol;
and/or the silver salt is one or more of AgTFA, AgOTf, AgBF 4 or AgSCF 3;
And/or the molar ratio of the silver salt to the compound 3 is 1.0-2.0;
And/or, the reaction is carried out under anhydrous conditions;
And/or the reaction temperature is 40-60 ℃;
And/or, the synthesis method of the compound 4 comprises the following steps: adding a solvent into the mixture of the compound 3 and the silver salt, and carrying out the reaction to obtain a compound 4; preferably, the reaction is carried out by mixing compound 3 and a silver salt under anhydrous conditions and adding a solvent.
6. A method for synthesizing a compound 5, which is characterized by comprising the following steps: in a solvent, carrying out the reaction shown as the following on the compound 4 under the action of a reducing agent to obtain a compound 5; the synthesis method of the compound 4 is as described in claim 4 or 5;
7. the method of synthesis according to claim 6,
the solvent is a mixed solvent of an organic solvent and water; the organic solvent is preferably an alcohol solvent and/or an ether solvent; the alcohol solvent is preferably one or more of methanol, ethanol and isopropanol; the ether solvent is preferably tetrahydrofuran; the volume ratio of the organic solvent to the water in the mixed solvent is preferably 2: 1-6: 1;
and/or the volume mol ratio of the solvent to the compound 4 is 12-20L/mol;
and/or the reducing agent is borohydride of alkali metal, preferably sodium borohydride;
And/or the molar ratio of the reducing agent to the compound 4 is 6.0-10.0;
and/or the temperature of the reaction is room temperature.
8. A method for synthesizing a compound A, which is characterized by comprising the following steps: under the action of inorganic base, carrying out hydrolysis reaction on the compound 5 as shown in the specification to obtain a compound A; the synthesis method of the compound 5 is as described in claim 6 or 7;
9. The method of synthesis according to claim 8,
The solvent is an alcohol solvent and/or an ether solvent; the alcohol solvent is preferably one or more of methanol, ethanol and isopropanol; the ether solvent is preferably tetrahydrofuran;
And/or the volume mol ratio of the solvent to the compound 5 is 10.5-26.3L/mol;
and/or, the inorganic base is hydroxide of alkali metal, preferably sodium hydroxide and/or potassium hydroxide;
And/or the inorganic base participates in the reaction in the form of aqueous solution of the inorganic base; the molar concentration of the aqueous solution of the inorganic base is preferably 1 to 10mol/L, more preferably 1 to 5 mol/L;
and/or the temperature of the hydrolysis reaction is 60-100 ℃.
10. A method for synthesizing 5-phenylpentanol compound 6, which comprises the steps of reacting compound A with (Boc) 2 O in a solvent to obtain 5-phenylpentanol compound 6, wherein the method for synthesizing compound A is as defined in claim 8 or 9;
11. The method of synthesis according to claim 10,
the solvent is halogenated hydrocarbon solvent and/or ether solvent; the halogenated hydrocarbon solvent is preferably chloroform; the ether solvent is preferably tetrahydrofuran;
and/or the volume mol ratio of the organic solvent to the compound A is 15-25L/mol;
and/or the molar ratio of the (Boc) 2 O to the compound A is 1.0-2.0;
And/or the dropping temperature of the (Boc) 2 O is-5 ℃;
and/or the temperature of the reaction is room temperature.
12. A compound 3, 4 or 5 having the structure:
CN201810551701.2A 2018-05-31 2018-05-31 Synthesis method of 5-phenylpentanol compound and intermediate thereof Active CN110551069B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810551701.2A CN110551069B (en) 2018-05-31 2018-05-31 Synthesis method of 5-phenylpentanol compound and intermediate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810551701.2A CN110551069B (en) 2018-05-31 2018-05-31 Synthesis method of 5-phenylpentanol compound and intermediate thereof

Publications (2)

Publication Number Publication Date
CN110551069A true CN110551069A (en) 2019-12-10
CN110551069B CN110551069B (en) 2022-10-04

Family

ID=68733838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810551701.2A Active CN110551069B (en) 2018-05-31 2018-05-31 Synthesis method of 5-phenylpentanol compound and intermediate thereof

Country Status (1)

Country Link
CN (1) CN110551069B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008253987A (en) * 2007-03-09 2008-10-23 Japan Science & Technology Agency METALLIC CATALYST AND MANUFACTURING METHOD OF OPTICALLY ACTIVE alpha-AMINO ACID DERIVATIVE
CN103788056A (en) * 2014-01-15 2014-05-14 上海交通大学 Chiral 1-substitutive-1-vinyl glycol, midbody and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008253987A (en) * 2007-03-09 2008-10-23 Japan Science & Technology Agency METALLIC CATALYST AND MANUFACTURING METHOD OF OPTICALLY ACTIVE alpha-AMINO ACID DERIVATIVE
CN103788056A (en) * 2014-01-15 2014-05-14 上海交通大学 Chiral 1-substitutive-1-vinyl glycol, midbody and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AJMAL KHAN等: "Palladium-Catalyzed Enantioselective Decarboxylative Cycloaddition of Vinylethylene Carbonates with Isocyanates", 《CHEM. EUR. J.》 *
FENG ZHONG等: "Catalytic Asymmetric Construction of Halogenated Stereogenic Carbon Centers by Direct Vinylogous Mannich-Type Reaction", 《J. AM. CHEM. SOC.》 *
HAI-JUN ZHANG等: "Direct Asymmetric Vinylogous and Bisvinylogous Mannich-Type Reaction Catalyzed by a Copper(I) Complex", 《J. AM. CHEM. SOC.》 *
MANDAR S. BODAS等: "An efficient stereoselective synthesis of (2S,3S)-3-hydroxy-2-phenylpiperidine", 《TETRAHEDRON LETTERS》 *
梁婷婷等: "铜催化对C-C 不饱和键铜氢化引发的多米诺反应", 《有机化学》 *

Also Published As

Publication number Publication date
CN110551069B (en) 2022-10-04

Similar Documents

Publication Publication Date Title
MX2008013842A (en) Improved process for the preparation of 6-alpha-hydroxy-n-alkylat ed opiates.
JP2023532317A (en) Intermediate for synthesizing camptothecin derivative, method for producing the same, and use thereof
Avila et al. Acid and base catalyzed Davis–Beirut reaction: experimental and theoretical mechanistic studies and synthesis of novel 3-amino-2H-indazoles
Cherry et al. Regioselective synthesis of 5-alkylidene and 5-(iodoalkylidene)-pyrrol-2 (5H)-ones by halolactamisation of (2Z, 4E)-dienamides and (Z)-alk-2-en-4-ynamides
Abushanab et al. Synthetic studies in the lsoxazoko [4, 5‐b] pyrazine system
CN111072642B (en) Preparation method of 5-succinimide chromone compound
CN110551069A (en) synthesis method of 5-phenylpentanol compound and intermediate thereof
CN107602570A (en) A kind of nitrogenous polynary and heterocyclic compound method of synthesis
CN109020864B (en) Application of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method
CN102924548B (en) Synthesis method of capecitabine
CN107778240A (en) A kind of preparation method of 6 phenylphenanthridinewith
CN114751852B (en) Preparation method of silodosin key intermediate
CN103204803A (en) Method used for synthesizing etoricoxib
CN105732648A (en) Nitrogen heterocyclic ring compound of pyrrolofuran and synthetic method
CN109422685A (en) A kind of synthetic method of N- acetyl group phenanthridines -6- amide and its derivative
CN105330550B (en) A kind of preparation method of optically active 1 cyclohexylethylamine
CN111057080B (en) Preparation method of boron-containing indolinone derivative
CN108440376B (en) Preparation method of ropinirole hydrochloride
CN111747879A (en) Large-process synthesis method of erexib
CN112300059B (en) Preparation method of PF-06651600 intermediate
CN114805231B (en) Synthesis method of p-NH2-Bn-NOTA
CN111747874B (en) Ericoxib intermediate and preparation method and application thereof
CN114573512B (en) Method for synthesizing C2-difluoro alkyl benzimidazole derivative
CN110386929B (en) Copper catalyst-mediated heterocycle-heterocycle C-N cross dehydrogenation coupling reaction method
CN110483494B (en) Chiral bisoxazoline-hydrogenated imidazole carbene salt compound, and synthetic method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant